Informed Pulse

NeueHealth (NYSE:NEUE) Stock Price Up 1.1% - Time to Buy?


NeueHealth (NYSE:NEUE) Stock Price Up 1.1%  - Time to Buy?

Shares of NeueHealth, Inc. (NYSE:NEUE - Get Free Report) were up 1.1% during mid-day trading on Thursday . The company traded as high as $7.39 and last traded at $7.39. Approximately 53,968 shares changed hands during mid-day trading, an increase of 91% from the average daily volume of 28,290 shares. The stock had previously closed at $7.31.

Separately, Royal Bank of Canada cut their price target on NeueHealth from $8.00 to $7.00 and set a "sector perform" rating for the company in a report on Monday, December 9th.

Get Our Latest Stock Report on NEUE

The firm has a fifty day moving average price of $6.89 and a 200 day moving average price of $5.79. The firm has a market cap of $61.19 million, a PE ratio of -0.14 and a beta of 0.58.

In other NeueHealth news, CEO George Lawrence Mikan III sold 16,803 shares of the firm's stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $4.18, for a total transaction of $70,236.54. Following the completion of the sale, the chief executive officer now owns 83,029 shares of the company's stock, valued at $347,061.22. This trade represents a 16.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jay Matushak sold 4,970 shares of the company's stock in a transaction on Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $36,430.10. Following the completion of the transaction, the chief financial officer now directly owns 17,747 shares in the company, valued at approximately $130,085.51. This trade represents a 21.88 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 58,658 shares of company stock valued at $377,034 over the last ninety days. Company insiders own 64.30% of the company's stock.

Several hedge funds have recently bought and sold shares of the stock. Partners Group Holding AG purchased a new stake in shares of NeueHealth in the 3rd quarter valued at approximately $463,000. Northern Trust Corp raised its position in NeueHealth by 66.8% in the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company's stock valued at $242,000 after purchasing an additional 13,074 shares during the period. Finally, Virtu Financial LLC acquired a new position in NeueHealth during the fourth quarter worth $76,000. Hedge funds and other institutional investors own 63.88% of the company's stock.

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider NeueHealth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NeueHealth wasn't on the list.

While NeueHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

Previous articleNext article

POPULAR CATEGORY

corporate

8375

miscellaneous

10835

wellbeing

8240

fitness

10989